Overview
Lobbying Costs
200,000€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
1.75 Fte (5)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
SFL Regulatory Affairs & Scientific Communication GmbH (SFL)
EU Transparency Register
31442479070-19 First registered on 02 Jul 2012
Goals / Remit
SFL Regulatory Affairs & Scientific Communication GmbH (SFL), a Veristat company, is a leading consultancy company providing integrated solutions to pharma, biotech & medtech companies within one consultancy. SFL’s core competencies: Regulatory Affairs, Medical Affairs, Public Affairs & Regulatory Intelligence, Quality Assurance, Pharmacovigilance, Supply Chain, Market Access, Legal & Healthcare Compliance.
SFL meets clients’ needs through every stage of the product lifecycle. Our team has a proven track record in specific areas of expertise & excellent understanding of products’ lifecycle.
Public Affairs Services: SFL advises organizations on engaging in the EU debate to shape regulatory & policy frameworks. Our team has extensive hands-on experience & proven success in supporting clients to contribute to EU healthcare laws & policies. Our services comprise strategic & operational public affairs support, intelligence, advocacy support & association management.Main EU files targeted
- EU Pharmaceutical Strategy
- European Health Union, HERA
- Implementation of Medical Devices Regulation and In-vitro Diagnostics Regulation
- Orphan Medicinal Products Regulation, Pediatric Regulation and their revision
- Revision of the EU general pharmaceutical legislation
- Incentives on medicinal products
- Advanced Therapy Medicinal Products Regulation
- Europe’s Beating Cancer Plan
- Clinical Trials Regulation and Clinical Trials Information System
- European Medicines Agency policy on publication of
clinical data for medicinal products for human use
- Draft Regulation on Substances of Human Origin
- Regulation on Health Technology Assessment
- Cross-border healthcare
- EUnetHTA
- EU pharmacovigilance system
- EU personalized medicine activities such as use of '-omics' technologies in the development of personalized medicine
- Access to Medicines
- Shortages of medicinal products and medical devices
- Horizon Europe
- European Data Strategy, Artificial Intelligence and Cybersecurity
- Data Governance Act and Data Act
- Digital infrastructure and cybersecurity
- Regulation on Artificial Intelligence
- European Health Data Space
- General Data Protection Regulation
- European Green Deal
- Circular Economy Action Plan
- EU strategy for chemicals sustainability
- EU industrial strategyAddress
Head Office
Aeschenvorstadt 52
Basel 4051
SWITZERLANDEU Office
Aeschenvorstadt 52
Basel 4051
SWITZERLANDWebsite
-
People
Total lobbyists declared
5
Employment time Lobbyists 50% 2 25% 3 Lobbyists (Full time equivalent)
1.75
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Professional consultancies
-
Networking
Affiliation
SFL is a member of Medtech & Pharma Platform (MPP).
SFL is a member of SWISS MEDTECH.
SFL is a member of the Round Table on Antibiotics.
SFL is a member of the British-Swiss Chamber of Commerce.Member organisations
None declared
-
Financial Data
Interests represented
Advances interests of their clients
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
200,000€
Major contributions in closed year
None declared
Clients for closed financial year
Clients list
Name Proposal Amount F. Hoffmann-La Roche Ltd Our work covers widely health policies and legislation in the European Union. In addition, policies and legislations impacting conditions applicable to the establishment and running of corporations are also covered. 100,000€ - 199,999€ Medtech & Pharma Platform (MPP) Our work as leading the Secretariat covers widely all policies and legislation relevant to the combined products, i.e. products consisting of a combined use of a medicinal product, medical device or in vitro diagnostic, including those with a digital component. 100,000€ - 199,999€ Clients for current financial year
Clients list
Name Medtech & Pharma Platform (MPP) F. Hoffmann-La Roche Ltd Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
SFL supports its clients with impact analysis and strategic communication advice on the dossiers and activities listed under ‘Main EU initiatives, policies and legislative files monitored by your organisation’. SFL advises on internal organizational matters to help clients formulate aligned positions and speak with one voice to regulators, policymakers and other stakeholders.
Other activities
None declared
- Meetings
Meetings
None declared
- Meetings